HIV genetic diversity: biological and public health consequences.
about
Rapid detection of HIV-1 proviral DNA for early infant diagnosis using recombinase polymerase amplificationHIV-1 Tat-based vaccines: an overview and perspectives in the field of HIV/AIDS vaccine development.Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.The challenge of HIV-1 antiretroviral resistance in Africa in the era of HAART.Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.The evolution of HIV-1 group M genetic variability in Southern Cameroon is characterized by several emerging recombinant forms of CRF02_AG and viruses with drug resistance mutationsCombination of V106I and V179D polymorphic mutations in human immunodeficiency virus type 1 reverse transcriptase confers resistance to efavirenz and nevirapine but not etravirine.T-cell immune responses against Env from CRF12_BF and subtype B HIV-1 show high clade-specificity that can be overridden by multiclade immunizationsThe changing face of HIV in Latin America and the CaribbeanNature, position, and frequency of mutations made in a single cycle of HIV-1 replication.Monitoring the quality of HIV-1 viral load testing through a proficiency testing program using dried tube specimens in resource-limited settings.CRF07_BC Strain Dominates the HIV-1 Epidemic in Injection Drug Users in Liangshan Prefecture of Sichuan, China.Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzeesVirus subtype-specific features of natural simian immunodeficiency virus SIVsmm infection in sooty mangabeysViral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria.Novel multiregion hybridization assay for the identification of the most prevalent genetic forms of the human immunodeficiency virus type 1 circulating in Portugal.Molecular assays for monitoring HIV infection and antiretroviral therapy.Small ruminant lentiviruses (SRLVs) break the species barrier to acquire new host range.Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy.Clinical, virologic, and immunologic correlates of HIV-1 intraclade B dual infection among men who have sex with men.Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections.Simian foamy virus infection in humans: prevalence and management.HIV testing strategies: test performance is important, but not sufficient.Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1.Voronoff to virion: 1920s testis transplantation and AIDS.Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections.Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users.Inference of global HIV-1 sequence patterns and preliminary feature analysis.The effect of human immunodeficiency virus type 1 (HIV-1) gp41 variability on antibody detection.Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon.Synthesis of novel biologically active methylene derivatives of sydnones
P2860
Q24634551-2E53E9EC-B837-441C-96BC-51F02985CDABQ30381447-45D325F6-1E99-47B1-B368-81F502066B4CQ30382590-6D0DF3F4-157C-47F9-BAA8-4B874184BD43Q30425595-BA4E1341-4405-41F4-8F1F-E9D5130806F5Q33476165-963FF7BF-F274-46BF-B217-9F3A1A092026Q33570778-6B776C73-56D8-42EA-9B73-EE9EA9F0F979Q33768822-FC85DA30-9FB6-48B3-9247-9473255809F7Q33833624-EBA10A0D-1A58-4604-A4B1-8091B4B7CA92Q34060467-FB4AA19D-2396-49D8-BC67-EBA0AF664FE0Q34120857-609D5CA7-2E70-4A59-A869-A84301FEEDCFQ35193119-6BBFDFF0-1CC2-4AF9-971C-D5E0E14BE8A9Q35589802-B3A9E01B-2DF6-40F5-8897-8B8D3224672CQ35914553-506AD99A-9D39-4A84-947B-84E10F6337A2Q35947635-9F028EA7-5AB8-4641-A166-E22823AC0E34Q36418462-E0233951-E907-4303-A05F-50B0EEC7539DQ36553956-33D981DA-4222-47E6-8EFB-A2FEF6AC3DB2Q36816024-66FA12F8-17A3-43F1-9265-6819AC610F57Q37083733-C7DFCACD-564B-49AB-8887-9B7FA24CCE95Q37150917-217E46B6-91E5-4001-A451-B5096B87D390Q37253688-521F48AE-0CE2-48F8-A203-395EDDCAACDBQ37333651-4045BA9F-2803-4A14-BA40-B5C4313E3F96Q37503347-ABBA021C-9CF6-421A-9CF6-71CDCED16A3AQ37845848-F6ED16C9-D7C0-4D38-B756-4D6D8B2F4A6FQ38088726-6BDE166D-0882-45B5-B024-A31FD5478B9AQ39531273-A909FFD0-4EB0-4604-893D-100A1BD20D5CQ41156500-4F3310FB-C939-431D-8083-B67181A58B27Q41920886-0308529B-DC95-4909-9056-4EB201B97300Q42279217-DE558279-C312-44F7-B40F-D3162AA16BDEQ45362788-A2DCDC09-7A49-4473-90ED-7198525D549BQ45367650-DC915B32-318D-4F72-8C00-0E687FEB6C1EQ57269201-84ED9FE7-357E-438A-8188-77DFA5DBBA18
P2860
HIV genetic diversity: biological and public health consequences.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
HIV genetic diversity: biological and public health consequences.
@ast
HIV genetic diversity: biological and public health consequences.
@en
type
label
HIV genetic diversity: biological and public health consequences.
@ast
HIV genetic diversity: biological and public health consequences.
@en
prefLabel
HIV genetic diversity: biological and public health consequences.
@ast
HIV genetic diversity: biological and public health consequences.
@en
P1433
P1476
HIV genetic diversity: biological and public health consequences.
@en
P2093
Isolde F Butler
Preston A Marx
P356
10.2174/157016207779316297
P577
2007-01-01T00:00:00Z